Obesity is a pressing global health issue that significantly contributes to morbidity and mortality. As healthcare professionals, we play a pivotal role in addressing this epidemic. This article aims to explore effective strategies for obesity management.
Obesity is a multifactorial condition, often influenced by genetic, environmental, and behavioral factors. A thorough understanding of these underlying causes is essential for effective management. Addressing these factors individually can help tailor personalized treatment plans.
Lifestyle modifications, including dietary changes, increased physical activity, and behavioral therapy, form the cornerstone of obesity management. Medical therapy may be considered for patients with a BMI of 30 or more or those with a BMI of 27 or more who have obesity-related comorbidities.
Bariatric surgery is an effective treatment for patients with severe obesity (BMI >40) or those with a BMI of 35 or more with serious comorbidities. It can result in significant weight loss and improvement or resolution of obesity-related conditions.
A multidisciplinary approach involving dietitians, psychologists, exercise physiologists, and medical practitioners is crucial for comprehensive obesity management. This approach ensures all aspects of the patient's health are addressed, improving long-term outcomes.
Prevention is a key component in managing the obesity epidemic. Public health interventions that promote healthy eating, regular physical activity, and healthy environments can help prevent obesity at a population level.
Managing obesity requires a comprehensive, multifaceted approach that addresses the root causes, employs both non-surgical and surgical interventions, and emphasizes prevention. As healthcare professionals, we must lead the charge in implementing these strategies, working collaboratively to improve patient outcomes and tackle this global health crisis.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation